Cargando…
Fulminant Adenoviral-Induced Hepatitis in Immunosuppressed Patients
Human adenovirus (HAdV) can often lead to fulminant hepatitis in immunocompromised patients, mostly after reactivation of HAdV. Different risk factors, e.g., transplantation and chemotherapy, increase the risk of developing a HAdV hepatitis. We retrospectively analyzed three patients who showed the...
Autores principales: | Kager, Juliane, Schneider, Jochen, Rasch, Sebastian, Herhaus, Peter, Verbeek, Mareike, Mogler, Carolin, Heim, Albert, Frösner, Gert, Hoffmann, Dieter, Schmid, Roland M., Lahmer, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323657/ https://www.ncbi.nlm.nih.gov/pubmed/35891439 http://dx.doi.org/10.3390/v14071459 |
Ejemplares similares
-
Fulminant Liver Failure after Treatment with a Checkpoint Inhibitor for Gastric Cancer: A Case Report and Review of the Literature
por: Dibos, Miriam, et al.
Publicado: (2023) -
(Seltene) infektiöse Hepatitiden als wichtige Differenzialdiagnose der unklaren Hepatopathie
por: Wührl, Michael, et al.
Publicado: (2022) -
Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study
por: Lahmer, Tobias, et al.
Publicado: (2021) -
Influence of a Structured Microbiological Endotracheal Monitoring Program on the Outcome of Critically Ill COVID-19 Patients: An Observational Study
por: Dibos, Miriam, et al.
Publicado: (2023) -
Risk factors for Herpes simplex virus (HSV) and Cytomegalovirus (CMV) infections in critically-ill COVID-19 patients
por: Fuest, Kristina E., et al.
Publicado: (2022)